IBDEI07O ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10080,1,4,0)
 ;;=4^238.2
 ;;^UTILITY(U,$J,358.3,10080,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,10081,0)
 ;;=242.00^^72^688^61
 ;;^UTILITY(U,$J,358.3,10081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10081,1,3,0)
 ;;=3^Goiter Toxic Dif/Graves Thyrotoxic Exoph
 ;;^UTILITY(U,$J,358.3,10081,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,10081,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,10082,0)
 ;;=272.2^^72^688^101
 ;;^UTILITY(U,$J,358.3,10082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10082,1,3,0)
 ;;=3^Xanthelasma
 ;;^UTILITY(U,$J,358.3,10082,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,10082,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,10083,0)
 ;;=360.40^^72^688^60
 ;;^UTILITY(U,$J,358.3,10083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10083,1,3,0)
 ;;=3^Globe/Eye Degenerative,Unspec
 ;;^UTILITY(U,$J,358.3,10083,1,4,0)
 ;;=4^360.40
 ;;^UTILITY(U,$J,358.3,10083,2)
 ;;=^268563
 ;;^UTILITY(U,$J,358.3,10084,0)
 ;;=360.42^^72^688^65
 ;;^UTILITY(U,$J,358.3,10084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10084,1,3,0)
 ;;=3^Hypertensive Blind/Absolute Glaucoma
 ;;^UTILITY(U,$J,358.3,10084,1,4,0)
 ;;=4^360.42
 ;;^UTILITY(U,$J,358.3,10084,2)
 ;;=^268565
 ;;^UTILITY(U,$J,358.3,10085,0)
 ;;=360.89^^72^688^59
 ;;^UTILITY(U,$J,358.3,10085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10085,1,3,0)
 ;;=3^Globe D/O,Other
 ;;^UTILITY(U,$J,358.3,10085,1,4,0)
 ;;=4^360.89
 ;;^UTILITY(U,$J,358.3,10085,2)
 ;;=^268581
 ;;^UTILITY(U,$J,358.3,10086,0)
 ;;=373.01^^72^688^5
 ;;^UTILITY(U,$J,358.3,10086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10086,1,3,0)
 ;;=3^Blepharitis,Ulcerative
 ;;^UTILITY(U,$J,358.3,10086,1,4,0)
 ;;=4^373.01
 ;;^UTILITY(U,$J,358.3,10086,2)
 ;;=^269053
 ;;^UTILITY(U,$J,358.3,10087,0)
 ;;=373.31^^72^688^49
 ;;^UTILITY(U,$J,358.3,10087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10087,1,3,0)
 ;;=3^Eyelid,Dermatitis,Eczematous
 ;;^UTILITY(U,$J,358.3,10087,1,4,0)
 ;;=4^373.31
 ;;^UTILITY(U,$J,358.3,10087,2)
 ;;=^269060
 ;;^UTILITY(U,$J,358.3,10088,0)
 ;;=373.34^^72^688^52
 ;;^UTILITY(U,$J,358.3,10088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10088,1,3,0)
 ;;=3^Eyelid,Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,10088,1,4,0)
 ;;=4^373.34
 ;;^UTILITY(U,$J,358.3,10088,2)
 ;;=^269064
 ;;^UTILITY(U,$J,358.3,10089,0)
 ;;=373.9^^72^688^37
 ;;^UTILITY(U,$J,358.3,10089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10089,1,3,0)
 ;;=3^Eyelid Inflammation,NOS
 ;;^UTILITY(U,$J,358.3,10089,1,4,0)
 ;;=4^373.9
 ;;^UTILITY(U,$J,358.3,10089,2)
 ;;=^269070
 ;;^UTILITY(U,$J,358.3,10090,0)
 ;;=374.21^^72^688^75
 ;;^UTILITY(U,$J,358.3,10090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10090,1,3,0)
 ;;=3^Lagophthalmos,Paralytic
 ;;^UTILITY(U,$J,358.3,10090,1,4,0)
 ;;=4^374.21
 ;;^UTILITY(U,$J,358.3,10090,2)
 ;;=^269091
 ;;^UTILITY(U,$J,358.3,10091,0)
 ;;=374.22^^72^688^74
 ;;^UTILITY(U,$J,358.3,10091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10091,1,3,0)
 ;;=3^Lagophthalmos,Mechanical
 ;;^UTILITY(U,$J,358.3,10091,1,4,0)
 ;;=4^374.22
 ;;^UTILITY(U,$J,358.3,10091,2)
 ;;=^269093
 ;;^UTILITY(U,$J,358.3,10092,0)
 ;;=374.23^^72^688^73
 ;;^UTILITY(U,$J,358.3,10092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10092,1,3,0)
 ;;=3^Lagophthalmos,Cicatricial
 ;;^UTILITY(U,$J,358.3,10092,1,4,0)
 ;;=4^374.23
 ;;^UTILITY(U,$J,358.3,10092,2)
 ;;=^269095
 ;;^UTILITY(U,$J,358.3,10093,0)
 ;;=374.31^^72^688^42
 ;;^UTILITY(U,$J,358.3,10093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10093,1,3,0)
 ;;=3^Eyelid Ptosis,Paralytic
 ;;^UTILITY(U,$J,358.3,10093,1,4,0)
 ;;=4^374.31
 ;;^UTILITY(U,$J,358.3,10093,2)
 ;;=^269097
 ;;^UTILITY(U,$J,358.3,10094,0)
 ;;=374.32^^72^688^41
 ;;^UTILITY(U,$J,358.3,10094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10094,1,3,0)
 ;;=3^Eyelid Ptosis,Myogenic
 ;;^UTILITY(U,$J,358.3,10094,1,4,0)
 ;;=4^374.32
 ;;^UTILITY(U,$J,358.3,10094,2)
 ;;=^269098
 ;;^UTILITY(U,$J,358.3,10095,0)
 ;;=374.33^^72^688^40
 ;;^UTILITY(U,$J,358.3,10095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10095,1,3,0)
 ;;=3^Eyelid Ptosis,Mechanical
 ;;^UTILITY(U,$J,358.3,10095,1,4,0)
 ;;=4^374.33
 ;;^UTILITY(U,$J,358.3,10095,2)
 ;;=^269099
 ;;^UTILITY(U,$J,358.3,10096,0)
 ;;=374.34^^72^688^26
 ;;^UTILITY(U,$J,358.3,10096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10096,1,3,0)
 ;;=3^Eyelid Blepharochalasis/Pseudoptosis
 ;;^UTILITY(U,$J,358.3,10096,1,4,0)
 ;;=4^374.34
 ;;^UTILITY(U,$J,358.3,10096,2)
 ;;=^15275
 ;;^UTILITY(U,$J,358.3,10097,0)
 ;;=374.41^^72^688^44
 ;;^UTILITY(U,$J,358.3,10097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10097,1,3,0)
 ;;=3^Eyelid Retraction/Lag
 ;;^UTILITY(U,$J,358.3,10097,1,4,0)
 ;;=4^374.41
 ;;^UTILITY(U,$J,358.3,10097,2)
 ;;=^269101
 ;;^UTILITY(U,$J,358.3,10098,0)
 ;;=374.43^^72^688^25
 ;;^UTILITY(U,$J,358.3,10098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10098,1,3,0)
 ;;=3^Eyelid Abn Innervation Synd
 ;;^UTILITY(U,$J,358.3,10098,1,4,0)
 ;;=4^374.43
 ;;^UTILITY(U,$J,358.3,10098,2)
 ;;=^269102
 ;;^UTILITY(U,$J,358.3,10099,0)
 ;;=374.46^^72^688^27
 ;;^UTILITY(U,$J,358.3,10099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10099,1,3,0)
 ;;=3^Eyelid Blepharophimosis
 ;;^UTILITY(U,$J,358.3,10099,1,4,0)
 ;;=4^374.46
 ;;^UTILITY(U,$J,358.3,10099,2)
 ;;=^15279
 ;;^UTILITY(U,$J,358.3,10100,0)
 ;;=374.50^^72^688^30
 ;;^UTILITY(U,$J,358.3,10100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10100,1,3,0)
 ;;=3^Eyelid Degen D/O,Unspec
 ;;^UTILITY(U,$J,358.3,10100,1,4,0)
 ;;=4^374.50
 ;;^UTILITY(U,$J,358.3,10100,2)
 ;;=^269106
 ;;^UTILITY(U,$J,358.3,10101,0)
 ;;=374.52^^72^688^34
 ;;^UTILITY(U,$J,358.3,10101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10101,1,3,0)
 ;;=3^Eyelid Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,10101,1,4,0)
 ;;=4^374.52
 ;;^UTILITY(U,$J,358.3,10101,2)
 ;;=^269108
 ;;^UTILITY(U,$J,358.3,10102,0)
 ;;=374.53^^72^688^36
 ;;^UTILITY(U,$J,358.3,10102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10102,1,3,0)
 ;;=3^Eyelid Hypopigmentation
 ;;^UTILITY(U,$J,358.3,10102,1,4,0)
 ;;=4^374.53
 ;;^UTILITY(U,$J,358.3,10102,2)
 ;;=^269109
 ;;^UTILITY(U,$J,358.3,10103,0)
 ;;=374.54^^72^688^35
 ;;^UTILITY(U,$J,358.3,10103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10103,1,3,0)
 ;;=3^Eyelid Hypertrichosis
 ;;^UTILITY(U,$J,358.3,10103,1,4,0)
 ;;=4^374.54
 ;;^UTILITY(U,$J,358.3,10103,2)
 ;;=^269111
 ;;^UTILITY(U,$J,358.3,10104,0)
 ;;=374.56^^72^688^39
 ;;^UTILITY(U,$J,358.3,10104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10104,1,3,0)
 ;;=3^Eyelid Oth Degenerative Skin D/O
 ;;^UTILITY(U,$J,358.3,10104,1,4,0)
 ;;=4^374.56
 ;;^UTILITY(U,$J,358.3,10104,2)
 ;;=^269114
 ;;^UTILITY(U,$J,358.3,10105,0)
 ;;=374.81^^72^688^33
 ;;^UTILITY(U,$J,358.3,10105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10105,1,3,0)
 ;;=3^Eyelid Hemorrhage
 ;;^UTILITY(U,$J,358.3,10105,1,4,0)
 ;;=4^374.81
 ;;^UTILITY(U,$J,358.3,10105,2)
 ;;=^269115
 ;;^UTILITY(U,$J,358.3,10106,0)
 ;;=374.82^^72^688^32
 ;;^UTILITY(U,$J,358.3,10106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10106,1,3,0)
 ;;=3^Eyelid Edema
 ;;^UTILITY(U,$J,358.3,10106,1,4,0)
 ;;=4^374.82
 ;;^UTILITY(U,$J,358.3,10106,2)
 ;;=^276852
 ;;^UTILITY(U,$J,358.3,10107,0)
 ;;=374.85^^72^688^45
 ;;^UTILITY(U,$J,358.3,10107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10107,1,3,0)
 ;;=3^Eyelid Vascular Anomalies
 ;;^UTILITY(U,$J,358.3,10107,1,4,0)
 ;;=4^374.85
 ;;^UTILITY(U,$J,358.3,10107,2)
 ;;=^269120
 ;;^UTILITY(U,$J,358.3,10108,0)
 ;;=374.86^^72^688^38
 ;;^UTILITY(U,$J,358.3,10108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10108,1,3,0)
 ;;=3^Eyelid Oth D/O,Floppy Eyelid Synd
 ;;^UTILITY(U,$J,358.3,10108,1,4,0)
 ;;=4^374.86
 ;;^UTILITY(U,$J,358.3,10108,2)
 ;;=^269121
 ;;^UTILITY(U,$J,358.3,10109,0)
 ;;=376.11^^72^688^89
 ;;^UTILITY(U,$J,358.3,10109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10109,1,3,0)
 ;;=3^Orbit Granuloma/Pseudotumor
 ;;^UTILITY(U,$J,358.3,10109,1,4,0)
 ;;=4^376.11
 ;;^UTILITY(U,$J,358.3,10109,2)
 ;;=^269176
 ;;^UTILITY(U,$J,358.3,10110,0)
 ;;=376.21^^72^688^93
 ;;^UTILITY(U,$J,358.3,10110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10110,1,3,0)
 ;;=3^Orbit Thyrotoxic Exophthalmos
 ;;^UTILITY(U,$J,358.3,10110,1,4,0)
 ;;=4^376.21
 ;;^UTILITY(U,$J,358.3,10110,2)
 ;;=^269181
 ;;^UTILITY(U,$J,358.3,10111,0)
 ;;=376.33^^72^688^83
 ;;^UTILITY(U,$J,358.3,10111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10111,1,3,0)
 ;;=3^Orbit Edema
 ;;^UTILITY(U,$J,358.3,10111,1,4,0)
 ;;=4^376.33
 ;;^UTILITY(U,$J,358.3,10111,2)
 ;;=^269186
 ;;^UTILITY(U,$J,358.3,10112,0)
 ;;=376.40^^72^688^82
 ;;^UTILITY(U,$J,358.3,10112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10112,1,3,0)
 ;;=3^Orbit Deformity,Unspec
 ;;^UTILITY(U,$J,358.3,10112,1,4,0)
 ;;=4^376.40
 ;;^UTILITY(U,$J,358.3,10112,2)
 ;;=^269191
 ;;^UTILITY(U,$J,358.3,10113,0)
 ;;=376.41^^72^688^90
 ;;^UTILITY(U,$J,358.3,10113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10113,1,3,0)
 ;;=3^Orbit Hypertelorism
 ;;^UTILITY(U,$J,358.3,10113,1,4,0)
 ;;=4^376.41
 ;;^UTILITY(U,$J,358.3,10113,2)
 ;;=^269192
 ;;^UTILITY(U,$J,358.3,10114,0)
 ;;=376.43^^72^688^81
 ;;^UTILITY(U,$J,358.3,10114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10114,1,3,0)
 ;;=3^Orbit Deformity d/t Bone Disease
 ;;^UTILITY(U,$J,358.3,10114,1,4,0)
 ;;=4^376.43
 ;;^UTILITY(U,$J,358.3,10114,2)
 ;;=^269196
 ;;^UTILITY(U,$J,358.3,10115,0)
 ;;=376.44^^72^688^80
 ;;^UTILITY(U,$J,358.3,10115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10115,1,3,0)
 ;;=3^Orbit Deform Assoc w/ Craniofac Deform
 ;;^UTILITY(U,$J,358.3,10115,1,4,0)
 ;;=4^376.44
 ;;^UTILITY(U,$J,358.3,10115,2)
 ;;=^269197
 ;;^UTILITY(U,$J,358.3,10116,0)
 ;;=376.51^^72^688^84
 ;;^UTILITY(U,$J,358.3,10116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10116,1,3,0)
 ;;=3^Orbit Enophthalmos d/t Atroph Orb Tissue
 ;;^UTILITY(U,$J,358.3,10116,1,4,0)
 ;;=4^376.51
 ;;^UTILITY(U,$J,358.3,10116,2)
 ;;=^269204
 ;;^UTILITY(U,$J,358.3,10117,0)
 ;;=376.52^^72^688^85
 ;;^UTILITY(U,$J,358.3,10117,1,0)
 ;;=^358.31IA^4^2
